Marinomed Biotech Management
Management criteria checks 1/4
Marinomed Biotech's CEO is Andreas Grassauer, appointed in Apr 2006, has a tenure of 18.25 years. directly owns 7.9% of the company’s shares, worth €1.30M. The average tenure of the management team and the board of directors is 18.3 years and 2.1 years respectively.
Key information
Andreas Grassauer
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 18.3yrs |
CEO ownership | 7.9% |
Management average tenure | 18.3yrs |
Board average tenure | 2.1yrs |
Recent management updates
Recent updates
A Look At The Fair Value Of Marinomed Biotech AG (VIE:MARI)
May 25Marinomed Biotech AG (VIE:MARI) Could Be Riskier Than It Looks
Feb 03Marinomed Biotech AG (VIE:MARI) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Apr 22Marinomed Biotech AG's (VIE:MARI) Analyst Just Slashed This Year's Estimates
Sep 22CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -€7m |
Dec 31 2023 | n/a | n/a | -€7m |
Sep 30 2023 | n/a | n/a | -€6m |
Jun 30 2023 | n/a | n/a | -€6m |
Mar 31 2023 | n/a | n/a | -€7m |
Dec 31 2022 | €307k | €222k | -€6m |
Sep 30 2022 | n/a | n/a | -€5m |
Jun 30 2022 | n/a | n/a | -€5m |
Mar 31 2022 | n/a | n/a | -€6m |
Dec 31 2021 | €300k | €200k | -€6m |
Sep 30 2021 | n/a | n/a | -€8m |
Jun 30 2021 | n/a | n/a | -€7m |
Mar 31 2021 | n/a | n/a | -€7m |
Dec 31 2020 | €324k | €200k | -€6m |
Sep 30 2020 | n/a | n/a | -€6m |
Jun 30 2020 | n/a | n/a | -€6m |
Mar 31 2020 | n/a | n/a | -€6m |
Dec 31 2019 | €440k | €200k | -€7m |
Sep 30 2019 | n/a | n/a | -€14m |
Jun 30 2019 | n/a | n/a | -€15m |
Mar 31 2019 | n/a | n/a | -€14m |
Dec 31 2018 | €177k | €177k | -€12m |
Compensation vs Market: Insufficient data to establish whether Andreas's total compensation is reasonable compared to companies of similar size in the Austrian market.
Compensation vs Earnings: Andreas's compensation has increased whilst the company is unprofitable.
CEO
Andreas Grassauer (55 yo)
18.3yrs
Tenure
€307,200
Compensation
Mr. Andreas Grassauer, PhD, is a Co-Founder of Marinomed Biotechnology GmbH in 2006 and serves as its Chairman of Management Board and has been Chief Executive Officer since 2006. Mr. Grassauer has co-foun...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 18.3yrs | €307.20k | 7.9% € 1.3m | |
Co-Founder | 18.5yrs | €299.60k | 7.9% € 1.3m | |
CFO & Member of Management Board | 5.9yrs | €311.70k | no data | |
Head of Investor Relations | no data | no data | no data |
18.3yrs
Average Tenure
55yo
Average Age
Experienced Management: MARI's management team is seasoned and experienced (18.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Chairman of Supervisory Board | 7.1yrs | €65.30k | no data | |
Independent Vice Chairwoman of the Supervisory Board | 5.7yrs | €20.00k | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Member of Supervisory Board | 2.1yrs | €7.50k | no data | |
Independent Member of Supervisory Board | 2.1yrs | €10.00k | no data | |
Member of Supervisory Board | 1.1yrs | no data | no data |
2.1yrs
Average Tenure
59yo
Average Age
Experienced Board: MARI's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.